• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    A Biobank for Long-term and Sustainable Research in the Field of Congenital Heart Disease in Germany

    2016-11-17 08:41:13ThomasPickardtEvaNiggemeyerbUlrikeBauerHashimAbdulKhaliqCompetenceNetworkforCongenitalHeartDefectsInvestigators
    Genomics,Proteomics & Bioinformatics 2016年4期

    Thomas Pickardt*,Eva Niggemeyerb,Ulrike M.M.Bauer,c,Hashim Abdul-Khaliq,Competence Network for Congenital Heart Defects Investigators

    1National Register for Congenital Heart Defects,13353 Berlin,Germany

    2Saarland University Medical Center,Department of Paediatric Cardiology,66421 Homburg,Germany

    3Competence Network for Congenital Heart Defects,13353 Berlin,Germany

    RESOURCE REVIEW

    A Biobank for Long-term and Sustainable Research in the Field of Congenital Heart Disease in Germany

    Thomas Pickardt1,*,a,Eva Niggemeyer1,b,Ulrike M.M.Bauer1,3,c,Hashim Abdul-Khaliq2,3,d,Competence Network for Congenital Heart Defects Investigators3

    1National Register for Congenital Heart Defects,13353 Berlin,Germany

    2Saarland University Medical Center,Department of Paediatric Cardiology,66421 Homburg,Germany

    3Competence Network for Congenital Heart Defects,13353 Berlin,Germany

    Received 22 December 2015;revised 14 March 2016;accepted 16 March 2016 Available online 27 April 2016

    Handled by Andreas Keller

    Congenital heart defects;Multi-center research;

    Biorepository;

    Genetic research;

    DNA

    Congenital heart disease(CHD)is the most frequent birth defect(0.8%-1%of all live births).Due to the advance in prenatal and postnatal early diagnosis and treatment,more than 90%of these patients survive into adulthood today.However,several mid-and long-term morbidities are dominating the follow-up of these patients.Due to the rarity and heterogeneity of the phenotypes of CHD,multicenter registry-based studies are required.The CHD-Biobank was established in 2009 with the aim to collect DNA from patients and their parents(trios)or from affected families,as wellas cardiovascular tissues from patients undergoing corrective heartsurgery for cardiovascular malformations.Clinical/phenotype data are matched to the International Paediatric and Congenital Cardiac Code(IPCCC)and the International Statistical Classification of Diseases and Related Health Problems 10th Revision(ICD-10).The DNA collection currently comprises samples from approximately 4200 participants with a wide range of CHD phenotypes. The collection covers about 430 trios and 120 families with more than one affected member.The cardiac tissue collection comprises 1143 tissue samples from 556 patients after open heart surgery.

    The CHD-Biobank provides a comprehensive basis for research in the field of CHD with high standards of data privacy,IT management,and sample logistics.

    Introduction

    Congenital heart disease(CHD)is the most common congenital organ malformation in the neonate.The prevalence of CHD is nearly stable and ranges from 8-10/1000[1,2].Due to the rapid improvement in prenataland postnatalearly diagnosis,as well as the advance in interventional,surgical,and postoperative treatment,the survival of offsprings with CHD has increased dramatically in the last two decades[3-6].Nevertheless,in moderate and severe congenital heart defects,anatomical correction could not be achieved.Intracardiac and extracardiac anatomical and functional residual defects which lead to mid-and long-term morbidities are stillchallenging and limit the long-term survivaland quality of life of these patients[7].

    The etiology of CHD,which is complex and associated with both genetic and environmentalcauses,is stilllargely unknown[8,9].With the growing number of adult CHD patients,information on recurrence risks and understanding the etiology will become increasingly important.Despite the introduction of novel genetic techniques such as next-generation sequencing(NGS),the molecular and genetic mechanisms underlying the development of CHD have not been clearly elucidated yet and the identification of particular defects remains challenging[10,11].

    Moreover,in contrast to the intensive research in the field of ischemic heart failure and the development of therapeutic and preventive approaches in adult patients,the therapeutic and preventive strategies for heart failure in patients with CHD are not adequately established.The molecular mechanisms of myocardial failure in neonatal myocardium after corrective surgery using the cardiopulmonary bypass(CPB),as well as in patients with residual pressure and volume overload,have not been clearly identified yet[12].

    The rarity of such congenital diseases and their heterogeneous morphological phenotypic and morphological manifestation make it difficult to study molecular and genetic origin as well as prevention and treatment[13].Therefore,CHD and its surgical correction are still associated with high mortality in the neonatal life,in contrast to older age groups[14,15].

    Although the neonatal myocardium may still have protective remodeling capacities such as stem cell and myocyte proliferation[16,17],the vulnerability of the neonatal myocardium to ischemia and other risk factors during the surgical manipulation and extracorporeal perfusion by CPB may represent significant risk factors[18,19],leading to myocardial dysfunction after heart surgery.On the other hand,residual adaptive mechanisms of the fetal heart such as cell proliferation and the presence of stem cells have been considered as possible adaptive capacities against stress and ischemic injury[16,17].Data on the remodeling processes in these patients during the transition from fetal to neonatal life are scarce and should be evaluated within the biobank on the basis of a standardized collection of myocardial tissues.

    Thus,the establishment of a nationwide research platform to overcome such challenges in the most common congenital organ malformations in the future is urgently needed. Moreover,extensive research cooperation should not be limited to nationwide research groups,but should also be extended to other countries and performed on an international level,as demonstrated by our network during the past five years(see below,section‘Cooperative projects and partner institutions”).

    Figure1 Structure of CNCHD and NRCHD

    Network and biobank infrastructure

    The CHD-Biobank is an integral part of the National Register for Congenital Heart Defects(www.kompetenznetz-ahf.de/en/ research/register-biobank,hereafter NRCHD),which serves as a core facility of the German Competence Network for Congenital Heart Defects(www.kompetenznetz-ahf.de/en/home,hereafter CNCHD).Both entities are non-profit organizations and operate independently of each other,thus guaranteeing the separation of sustainable and long-term patient data administration and storage on the one hand and research activities on the other hand(Figure 1).The management and coordination for both entities are performed by a central office,the Network Management Office(NMO).The NMO is responsible for patient registration,administration,and consent management.It is also responsible for sample collection,validation of clinical/phenotype data,and research/study management,as well as network communication and operation of database systems.The whole network is headed by a Steering Committee that includes board members from both NRCHD and CNCHD.An essential element of the CHD-Biobank infrastructure is the cooperation with the Central Biomaterial Bank Charite′Berlin(ZeBanC,biobank.charite.de)that carries out central processing of blood and saliva samples and storage of DNA.

    While numerous medical centers and institutions are involved in various studies of the CNCHD,the CHDBiobank project is maintained by eight institutions:the departments of pediatric cardiology and/or heart surgery at the University Hospitals of Kiel,Erlangen,F(xiàn)reiburg,and Homburg,the University Heart Center of Leipzig,the Heartand Diabetes Center NRW(Bad Oeynhausen),the German Heart Centre Munich,and the German Heart Institute Berlin. Further inclusion of more hospitals is scheduled.Participation is bound to the implementation of all required work flows,and the participating institutions confirm the acceptance of CHDBiobank policies and standard operation procedures(SOPs),based on a collaboration agreement.

    Study population

    The CHD-Biobank collects biomaterials from patients with any diagnosed congenital heart defect.For reference analyses,samples of patients’parents(trios)and relatives(from families with an accumulation of CHD)are also included systematically.

    Legal framework—ethics and data privacy

    Based on an appropriate patient informed consent,approval by eight ethics committees in Germany and a data privacy concept(registered with the Berlin Official for Data Protection and Freedom of Information/No.531.390),NRCHD is legally authorized to(i)receive and store medical data and samples from all age groups for an indefinite time,(ii)continuously request latest medical reports from the attending physicians,(iii)re-contact registered participants,(iv)hold the right to use the data and samples collected,and(v)make register data and samples available to interested scientists and research institutions for future studies and within the scope of international cooperation.

    Protection of personal data

    Primary patient codes(pseudonyms)are kept in a separate database(PID-generator,see below)to prevent unauthorized access to re-identifying information.All samples are tagged with a second-level code that is designated only for internal use,i.e.,the processing and storage at the collaborating laboratory facility,where staff members are not able to obtain information on the identity of sample donors or their health conditions.When samples or aliquots of samples are released to research facilities,a third-level code is generated,impeding the re-identification of patients.

    The use of data

    The use of data by research institutions is subject to the CNCHD policies and a material transfer agreement(MTA)that commits data recipients to handle data according to legal regulations and applicable laws,e.g.,preventing third parties from having access to or using samples and data.

    Patients’right of self-determination

    The storage of samples is generally intended for an indefinite time and yet-to-define research purpose.In orderto give patients the opportunity to obtain a continuous update regarding the CHD-Biobank’s research activities(and to withdraw their consent,if required),the NRCHD has implemented a web-based patient information platform(www.herzregister.de).Sample donors can object to the CHD-Biobank’s storing and using their data/samples at any time.Donors can opt between the anonymization and deletion/destruction of data/samples.

    Database systems and ID management

    In consistence with the NRCHD’s overall concept,the CHDBiobank applies a central patient and sample ID management.Patient codes are generated by a so-called PID-generator[20],a software program that creates 8-digit/ alphanumeric pseudonyms on the basis of the patients’personally-identifiable information.The latter is divided into hard and soft criteria and phonetic algorithms,thus ensuring the unambiguity of a patient’s data upon pseudonymization. The PID-generator allows a hospital-independent assignment of patients and facilitates multicenter and longitudinal investigations.

    For clinicaldata and sample acquisition,the NRCHD uses a 3-tier server architecture consisting of Oracle 10g,which is a customized version of ixserv4(ixmid Technologie GmbH,www.ixmid.com),as the application layer,and a Tomcat web server for the presentation layer.The database for biomaterials includes a web frontend with a defined form structure that enables the acquisition of sample-related data(reception,processing,quality,dissemination,tracking,etc.)and facilitates the collection and management of samples from several locations.Sample ID management is performed using uniform barcode-labeling systems including barcoded sample containers with unique alphanumeric codes.

    Clinicaldata

    Clinical data for each participant are obtained via medical reports(doctor’s letters)that are provided by the treating physicians or by the patients themselves.A standardized dataset is recorded from each patient upon registration.The recorded data include(1)personal data:surname,birth name,first name,date of birth,sex,address and contact details,familiar status and relations(acquisition of families),place of birth including federalstate,maritalstatus,and nationality,and(2)medical/phenotype data:maternal age at birth,gestational age,multiple pregnancy,birth weight,prenatal diagnosis of CHD,all congenital and acquired cardiovascular diagnoses,procedures,and additional diseases/disorders.If necessary for accuracy and data validation,further medical findings,e.g.,additional data of magnetic resonance imaging(MRI)/echocardiographic analysis,are requested from the treating physicians.In addition,medical reports are obtained regularly to continuously update/complete the medical database.

    Medical data are coded according to(i)the International Statistical Classification of Diseases and Related Health Problems 10th Revision(ICD-10)and(ii)the International Paediatric and Congenital Cardiac Code(IPCCC)of the International Society for Nomenclature of Pediatric and Congenital Heart Disease comprising 206 different main diagnoses for CHD(Table 1)in order to cover the high variability of CHD phenotypes and conditions.For a rough classification we assign affected sample donors to 29 diagnosis groups(see below,section‘Current state of sample collection”).

    Table1 Comparison between ICD-10 and IPCCC for the classification of congenital heart defects

    Procedures for the collection,processing and storage of samples

    The CHD-Biobank collects EDTA-blood(Sarstedt SMonovette K3E 2.7/4.9/9.0 ml,depending on donor age)and saliva samples(DNAGenotek/Oragene OG-500 and OG-575)for the extraction of DNA,as well as cardiac tissue samples(snap-freezing in liquid nitrogen).The latter are obtained within the scope of open heart surgery during which fractions of tissue accumulate,which would be disposed of otherwise.

    Blood/saliva collection and DNA extraction

    Two means of sample acquisition are in place.Process A is used for the acquisition of blood and saliva samples from patients that are already registered,and their relatives.Patients are contacted by the NMO and asked for participation in the CHD-Biobank project.Adult patients or sample donors,after returning written consent,receive a blood or saliva sample kit. For blood taking,sample donors address a physician of their choice.Blood or saliva samples are sent to ZeBanC.Process A is most suitable for recruiting families and twins via direct contact to participants of the NRCHD.On the other hand,Process B is used for the acquisition of blood samples from patients not yettaking partin the NRCHD.Collaborating hospitals are regularly provided by the NMO with blood kits that include coded documents(informed consent and sample data sheets)and barcoded sample containers that are linked to the respective documents(recorded in the CHD-Biobank database).Within the scope of scheduled examinations,patients are informed and blood withdrawal takes place if they agree.The responsible physician forwards the signed consent form together with a medicalreport to the NMO,and the blood sample to ZeBanC.

    A small amount of blood sample is retained for control purposes and stored at-80°C.Saliva and the remaining blood samples are further processed at ZeBanC.For the automated extraction of DNA from blood and saliva,ZeBanC uses the Freedom EVO HSM 2.0 Workstation and the ReliaPrep Large Volume HTgDNA Isolation System(Promega/Tecan).The processing,aliquoting,and storage of samples are documented via the online-accessible CHD-Biobank database.The documented data include information with respect to the date of blood taking,dispatch and arrival,blood volume/quality,extraction-related information/specifications,DNA purity,gel-quality check,concentration,volume and aliquotting. DNA is stored at-20°C.

    Figure2 Tissue-sample collection kit

    Tissue samples from open heart surgery

    The NMO provides specific tissue sample kits(Figure 2)for all participating departments.A sample kit comprises fivecryotubes(FluidX,1.8 ml),each of which is provided with a unique identifier(2D+1D barcodes),and a standardized sample acquisition form,tagged with the identifiers of the above tubes,printed as 1D-barcodes.Tubes and acquisition form are therefore already linked prior to their usage. Moreover,the acquisition form contains a list of heart tissue types that have been pre-defined by the Network surgeons.

    When tissue kits are allocated to a certain patient,the surgical team can collect tissue samples without the need of further marking/labeling tubes.The type of tissue that is placed in one of the five tubes is readily designated:tube caps contain inserts in different colors which are reproduced as dots alongside the list of tissue types;then the corresponding dot just has to be ticked on the acquisition form.

    Samples are snap-frozen in liquid nitrogen and then stored in the gas phase of liquid nitrogen.The samples are stored in local facilities at the participating medical centers.All sample data(vial code,type of tissue,acquisition date,position in the nitrogen-storage container)are entered electronically via web interface into the CHD-Biobank database.

    Sample quality management

    All work flows have been defined in SOPs and are revised and adjusted continuously according to technological progress. SOPs conform to or are based on the International Society for Biological and Environmental Repositories(ISBER)recommendations(http://www.isber.org).The following measures have been introduced in order to maintain high quality standards regarding the logistics and infrastructure of the CHDBiobank.

    Uniform protocols and work flows

    The NMO team provides an efficient data and sample management,the implementation of harmonized protocols and work flows,standardized logistics,efficient central administration,and a continuous risk assessment.

    Guideline-based patient contact

    Recruitment of patients and families is accompanied by substantial guideline-based telephone interviews performed by NMO staff members that are specifically instructed and allowed to initiate and hold contact to register participants.

    On-site visits

    Participating hospitals are controlled through on-site visits by NMO staff members at least once a year,including the instruction of hospitalstaff members involved in data and sample collection,as well as documentation.

    Permanent availability and support

    The NMO team permanently keeps in touch with the responsible hospital staff members and provides them with support.

    Web-based data entry

    Information relevant to sample quality,acquisition,and processing procedures is recorded in the online-accessible CHD-Biobank database.The NMO team monitors data entry in realtime.

    Use of 1D/2D barcodes

    For nitrogen storage of samples,F(xiàn)luidX Cryovials with 2D-barcode jackets are used.The identification and recording of samples occur via barcode reading(linear-and 2D-barcode readers)only.

    Secure nitrogen storage and handling

    For tissue storage,the CHD-Biobank is equipped with Cryotherm Biosafe 120 MD containers providing an onlineaccessible,permanent all-over control and complete documentation of temperature and nitrogen filling status. For incorporating and disseminating samples,a working procedure preventing thawing and refreezing has been implemented.

    Network policies and use of the sample collection

    The NRCHD is a sustainable legal entity that is eligible to receive,store,and use data and samples from patients with CHD for research purposes.The sample donors transfer the right to use their biomaterials for scientific purposes to the NRCHD,which reserves the right to use as long as sample donors do not withdraw their consent.

    Use and access regulations and policies(see www.kompetenznetz-ahf.de/en/research/initiating-new-projects)comprise(i)general rules for cooperative studies,(ii)defined forms/ templates for research proposals,(iii)a defined description of the decision process,and(iv)publication guidelines.

    The CHD-Biobank offers researchers both the option of using existing samples and associated demographic and medical data,as well as the option of utilizing the CHD-Biobank infrastructure for a prospective recruitment of sample donors for specific studies.This service is open to all researchers or scientists with relevant expertise in the field of genetics and CHD and is not limited to members of the CNCHD.

    In order to participate,researchers have to submit a research proposal to the NMO.Research proposals are evaluated by the Scientific Board,which consists of experts in the fields of(pediatric)cardiology,epidemiology,human genetics,basic research,biometry/statistics,and ethics/health care law. Moreover,the Board comprises a representative of the German umbrella organization for children with CHD(BVHK e.V.).The final decision is made by the Steering Committee of the CNCHD and the representatives of the institutions where the samples have been collected,based on criteria such as a project’s feasibility,the precisely-defined objective,acceptance within the CHD research community,and stringent scheduling.Appropriate expertise in the field of interest is therefore a prerequisite.

    Upon approval,collaborating research groups and institutions must agree to make,after completion and publicationof their study,exploitable data such as sequence data available for being used by research groups in future studies.

    Sustainability

    Since January 2015,the NRCHD is supported by the newly established German Center for Cardiovascular Research(DZHK).Within this close cooperation,a comprehensive sustainable research network could be established,which covers congenital and acquired cardiovascular diseases in children and adults.

    Table2 Outline of the current CHD-Biobank DNA collection

    Figure3 Age distribution of the affected donors

    Table3 Distribution of the affected donors by diagnosis groups

    Current state of sample collection

    Table 2 gives an outline of the current DNA collection of the CHD-Biobank(as of March 2016):the collection comprises DNA samples from 4602 donors,including 2928 affected donors,covering a wide range of CHD phenotypes.1674 donors are non-affected relatives,since the CHD-Biobank focuses on the inclusion of whole families when more than one affected member is present,and the enrollment of trios(affected children and their healthy parents).In addition to family and trio samples,the inclusion of twins is crucial for research on etiology and genetic factors of CHDs as well. The CHD-Biobank recruits families and twins mainly by direct contact to registered participants via Process A(as described in section‘‘Blood/saliva collection and DNA extraction”).

    The breakdown of sample donors by age groups(Figure 3,documented age when samples were taken)reveals the predominance of underage patients(0-17 years),which represent more than 70%of the affected donors.

    Table 3 shows the distribution of the 29 diagnosis groups that we use for rough classification of the affected donors. The distribution does not reflect the average distribution of CHDs,since the CHD-Biobank focuses mainly on medium or severe,complex heart defects.

    While the majority of children born with CHDs do not have other birth defects(isolated CHD),20%-30%of cases occur in association with other,extracardiac anomalies or as part of a syndrome(syndromic CHD).Figure 4 shows the distribution of syndromes/disorders among the affected donors in the CHD-Biobank.

    For DNA extraction,9 ml of blood are withdrawn from adults.In acordance with the German ethical guidelines regarding underage participants,amounts of maximally 9 ml(age 3-17),5 ml(age 1-3),and 2.5 ml(below age 1)of blood are taken.Moreover,the ethics commission specifies that blood to be used for scientific purposes may only be taken from underage patients within the scope of a medicalexamination.We therefore additionally implemented saliva sample kits(DNAGenotek,Oragene,standard amount of 2 ml saliva)for DNA acquisition from affected,underage donors beyond medical examinations and for non-affected siblings.

    Figure4 Distribution of the affected donors born with additional syndromes/disorders

    Figure5 Type and number of tissue samples from heart surgery

    The automated extraction method for EDTA-blood on average yields 15.2μg DNA from 1 ml EDTA-blood and 16.8μg DNA from 1 ml of saliva.In addition to the routine control via gel electrophoresis and absorbance ratios 260/280 and 260/230 nm,the quality of DNAfrom 1147 sample donors has been checked within the scope of the cooperative project with the Wellcome Trust Sanger Institute(WTSI,Cambridge/UK).In more than 98%of samples,whole exome-or panel-sequencing was successful.

    Figure 5 shows the tissue samples that have been collected so far at the heart surgery departments of the university hospitals of Kiel,Erlangen,and Saarland/Homburg,as well as the German Heart Institute in Berlin.In total,1295 tissue samples have been collected from 659 patients,which are listed in Figure 5 according to the tissue type.An RNA quality control analysis of 20 tissue samples within the scope of our cooperative project with the Department of Pediatric Cardiology and Critical Care at Hannover Medical School revealed RNA integrity number(RIN)values of 8.2-9.4,indicating a high quality of the RNA generated.

    Cooperative projects and partner institutions

    At the time when the CHD-Biobank was initiated(2008/09),research on CHD genetics was only slightly established in Germany,partially due to the limited availability of samples. We therefore started cooperative projects on an international levelfrom the beginning.A number of projects have since thenbeen completed and further projects are in progress or in preparation.Projects include candidate gene approaches,chip-based copy number variation(CNV)analysis,and various NGS approaches.Up to now,a total of 1588 DNA samples of the affected and non-affected donors,as well as 36 tissue samples from heart surgery,have been provided for various research studies(Table 4).

    Table4 Cooperative projects and partner institutions

    Conclusions

    Research activities including molecular mechanisms of the development of cardiovascular malformations and several associated long-term morbidities are increasingly becoming a substantialsubject of genetic studies,largely due to sequencing capacities being available and a more routine use of bioinformatic analysis techniques.

    The identification of the causes and underlying molecular genetic processes,and an improved understanding of the pathologic mechanisms of long-term morbidities,are the prerequisites of developing new prevention strategies and treatment methods for patients with CHD.In particular,for patients with moderate and severe CHD in their early life,morbidities after successful operative treatment are now challenging their long-term survival and quality of life.Unfortunately,there are only scarce data on molecular mechanisms underlying myocardial systolic and diastolic dysfunction and possible therapeutic targets in the left and right ventricle. Similarly,data from patients having a morphologically single ventricle with heterogeneous anatomy are rare as well. The genetic mechanisms underlying several extracardiac morbidities,including hypoplasia and inadequate pulmonary growth in patients with restricted pulmonary perfusion,rapid growth and dilatation of the ascended aorta in patients with univentricular heart or tetralogy of Fallot and pulmonary atresia,are currently unknown.Thus,prospective clinical and genetic trials in larger cohorts are needed.These can only be performed on the basis of a nationwide registry and biobank.

    The CHD-Biobank includes comprehensive representative genetic materials of patients and their parents as well as further relatives,covering severe and mild CHD.The Network Management Team is currently increasing the efforts to include more families with accumulation of congenital cardiomyopathies.

    The rising number of requests for collaboration from numerous national and international research institutions can be regarded as an indication for the high quality of samples and phenotype data deposited in our biobank.

    The described biobank may represent a future platform for prospectively recruiting cohorts of patients with complex CHD,including the comprehensive phenotypic and genetic characterization in early childhood,as well as repeated clinical and cardiac follow-up and assessments at standardized time intervals.Such an approach may be the basis to develop individualized medical treatment and care for patients with these rare and complex CHDs.

    Authors’contributions

    TP,EN,UMMB,and HAK have made equal contributions to the biobank concept and design,and preparation of the manuscript.HAK is the Speaker of the Network and UMMB is the Managing Director of the Network.Allauthors have read and approved the final manuscript.

    Competing interests

    The authors declare that there are no competing interests.

    Acknowledgments

    The authors are grateful to all sample donors who participated in the CHD-Biobank.We thank the following collection sites: Herz-und Diabeteszentrum NRW/Bad Oeynhausen,Kinderherzzentrum/Zentrum fu¨r angeborene Herzfehler,Klinik fu¨r Kinderkardiologie und angeborene Herzfehler(D.Kececioglu),Klinik fu¨r Kinderherzchirurgie und angeborene Herzfehler(E.Sandica);Deutsches Herzzentrum Berlin,Klinik fu¨r angeborene Herzfehler und Kinderkardiologie(F.Berger,O. Miera,S.Ovroutski,B.Peters,K.Schmitt,S.Schubert),Klinik fu¨r die Chirurgie Angeborener Herzfehler/Kinderherzchirurgie(J.Photiadis);Universita¨tsklinikum Erlangen/ Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg,Kinderkardiologische Abteilung(S.Dittrich,O.Toka),Medizinische Klinik 2-Kardiologie und Angiologie(U.Gundlach),Kinderherzchirurgische Abteilung(R.Cesnjevar);Universita¨ts-Herzzentrum Freiburg Bad Krozingen/Freiburg,Zentrum fu¨r Kinder-und Jugendmedizin,Klinik fu¨r Angeborene Herzfehler/Pa¨diatrische Kardiologie(B.Stiller),Klinik fu¨r Herz-und Gefa¨?chirurgie(F.Beyersdorf),Klinik fu¨r Herzund Gefa¨?chirurgie,Sektion Kinderherzchirurgie(J.Kroll);Universita¨tsklinikum Schleswig-Holstein/Kiel,Klinik fu¨r angeborene Herzfehler und Kinderkardiologie(H.H.Kramer,J.T.Cremer),Klinik fu¨r Herz-und Gefa¨?chirurgie(J. Scheewe);Herzzentrum Leipzig,Klinik fu¨r Kinderkardiologie(I.Da¨hnert,P.Kinzel),Klinik fu¨r Herzchirurgie/Kinderherz chirurgie(M.Kostelka);Deutsches Herzzentrum Mu¨nchen,Klinik fu¨r Kinderkardiologie und Angeborene Herzfehler(P. Ewert,A.Hager,H.Kaemmerer,N.Nagdyman,J.Schoetzau),Klinik fu¨r Herz-und Gefa¨?chirurgie(R.Lange).Universita¨tsklinikum des Saarlandes/Homburg,Klinik fu¨r Pa¨diatrische Kardiologie(T.Ra¨dle-Hurst,A.Rentzsch),Klinik fu¨r Thorax-und Herz-Gefa¨?-Chirurgie(H.J.Scha¨fers). We would like to acknowledge the excellent cooperation with our partner biobank Central Biomaterial Bank Charite′Berlin,ZeBanC for sample processing and storage of biomaterials. This work was supported by the Competence Network for Congenital Heart Defects which is funded by the Federal Ministry of Education and Research of Germany(BMBF;Grant No.01GI0601)until 2014 and,in part,supported by the DZHK(German Centre for Cardiovascular Research)(as of 2015).

    [1]Hoffman JI,Kaplan S.The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.

    [2]Schwedler G,Lindinger A,Lange PE,Sax U,Olchvary J,Peters B,et al.Frequency and spectrum of congenital heart defects among live births in Germany:a study of the competence network for congenital heart defects.Clin Res Cardiol 2011;100:1111-7.

    [3]Marelli AJ,Mackie AS,Ionescu-Ittu R,Rahme E,Pilote L. Congenital heart disease in the general population:changing prevalence and age distribution.Circulation 2007;115:163-7.

    [4]Kovacs AH,Verstappen A.The whole adult congenital heart disease patient.Prog Cardiovasc Dis 2011;53:247-53.

    [5]Sable C,F(xiàn)oster E,Uzark K,Bjornsen K,Canobbio MM,Connolly HM,et al.Best practices in managing transition to adulthood for adolescents with congenital heart disease:the transition process and medicaland psychosocialissues:a scientific statement from the American Heart Association.Circulation 2011;123:1454-85.

    [6]Moons P,Bovijn L,Budts W,Belmans A,Gewillig M.Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium.Circulation 2010;122:2264-72.

    [7]Tennant PW,Pearce MS,Bythell M,Rankin J.20-year survival of children born with congenital anomalies:a population-based study.Lancet 2010;375:649-56.

    [8]Zhu H,Kartiko S,F(xiàn)innell RH.Importance of gene-environment interactions in the etiology of selected birth defects.Clin Genet 2009;75:409-23.

    [9]Ou Y,Mai J,Zhuang J,Liu X,Wu Y,Gao X,et al.Risk factors of different congenital heart defects in Guangdong,China.Pediatr Res 2016;79:549-58.

    [10]Gelb BD,Chung WK.Complex genetics and the etiology of human congenital heart disease.Cold Spring Harb Perspect Med 2014;4:a013953.

    [11]Lalani SR,Belmont JW.Genetic basis of congenital cardiovascular malformations.Eur J Med Genet 2014;57:402-13.

    [12]Reddy S,Bernstein D.Molecular mechanisms of right ventricular failure.Circulation 2015;132:1734-42.

    [13]Marian AJ.Copy number variants and the genetic enigma of congenital heart disease.Circ Res 2014;115:821-3.

    [14]Wang Y,Liu G,Canfield MA,Mai CT,Gilboa SM,Meyer RE,et al.Racial/ethnic differences in survival of United States children with birth defects:a population-based study.J Pediatr 2015;166:819-26.

    [15]Benziger CP,Stout K,Zaragoza-Macias E,Bertozzi-Villa A,F(xiàn)laxman AD.Projected growth of the adult congenital heart disease population in the United States to 2050:an integrative systems modeling approach.Popul Health Metr 2015;13:29.

    [16]Simpson DL,Mishra R,Sharma S,Goh SK,Deshmukh S,Kaushal S.A strong regenerative ability of cardiac stem cells derived from neonatal hearts.Circulation 2012;126:46-53.

    [17]Mahmoud AI,Kocabas F,Muralidhar SA,Kimura W,Koura AS,Thet S,et al.Meis1 regulates postnatal cardiomyocyte cell cycle arrest.Nature 2013;497:249-53.

    [18]Karimi M,Wang LX,Hammel JM,Mascio CE,Abdulhamid M,Barner EW,et al.Neonatal vulnerability to ischemia and reperfusion:cardioplegic arrest causes greater myocardial apoptosis in neonatal lambs than in mature lambs.J Thorac Cardiovasc Surg 2004;127:490-7.

    [19]Gombosova I,Boknik P,Kirchhefer U,Knapp J,Luss H,Muller FU,et al.Postnatal changes in contractile time parameters,calcium regulatory proteins,and phosphates.Am J Physiol 1998;274:H2123-32.

    [20]Faldum A,Pommerening K.An optimal code for patient identifiers.Comput Methods Programs Biomed 2005;79:81-8.

    [21]Postma AV,van Engelen K,van de Meerakker J,Rahman T,Probst S,Baars MJ,et al.Mutations in the sarcomere gene MYH7 in Ebstein anomaly.Circ Cardiovasc Genet 2011;4:43-50.

    [22]van Engelen K,Postma AV,van de Meerakker J,Roos-Hesselink JW,Helderman-van den Enden AT,et al.Ebstein anomaly may be caused by mutations in the sarcomere protein gene MYH7. Neth Heart J 2013;21:113-7.

    [23]Tagariello A,Breuer C,Birkner Y,Schmidt S,Koch A,Cesnjevar R,et al.Functional null mutations in the gonosomal homologue gene TBL1Y are associated with non-syndromic coarctation of the aorta.Curr Mol Med 2012;2:199-205.

    [24]Arndt AK,Schafer S,Drenckhahn JD,Sabeh MK,Plovie ER,Caliebe A,et al.Fine mapping of the 1p36 deletion syndromeidentifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet 2013;93:67-77.

    [25]Bansal V,Dorn C,Grunert M,Klaassen S,Hetzer R,Berger F,et al.Outlier-based identification of copy number variations using targeted resequencing in a small cohort of patients with tetralogy of Fallot.PLoS One 2014;9:e85375.

    [26]Al Turki S,Manickaraj AK,Mercer CL,Gerety S,Hitz MP,Lindsay S,et al.Rare variants in NR2F2 cause congenital heart defects in humans.Am J Hum Genet 2014;94:574-85.

    [27]Moosmann J,Uebe S,Dittrich S,Ru¨ffer A,Ekici AB,Toka O. Novellocifor non-syndromic coarctation of the aorta in sporadic and familial cases.PLoS One 2015;10:e0126873.

    *Corresponding author.

    E-mail:pickardt@kompetenznetz-ahf.de(Pickardt T).

    aORCID:0000-0003-0019-6325.

    bORCID:0000-0001-6590-8034.

    cORCID:0000-0002-6317-3609.

    dORCID:0000-0002-5752-5866.

    Peer review under responsibility of Beijing Institute of Genomics,Chinese Academy of Sciences and Genetics Society of China.

    http://dx.doi.org/10.1016/j.gpb.2016.03.003

    1672-0229?2016 The Authors.Production and hosting by Elsevier B.V.on behalf of Beijing Institute of Genomics,Chinese Academy of Sciences and Genetics Society of China.

    This is an open access article under the CC BY license(http://creativecommons.org/licenses/by/4.0/).

    国产精品日韩av在线免费观看| 啦啦啦观看免费观看视频高清| 老司机福利观看| 美女高潮的动态| 欧美3d第一页| 亚洲欧美精品综合久久99| 国产美女午夜福利| 性欧美人与动物交配| 欧美中文日本在线观看视频| 欧美色欧美亚洲另类二区| 欧美中文综合在线视频| 国产熟女xx| 午夜福利高清视频| 国产av不卡久久| 在线观看午夜福利视频| 欧美国产日韩亚洲一区| 99久久九九国产精品国产免费| 99国产极品粉嫩在线观看| 天堂√8在线中文| 国产精品久久久久久人妻精品电影| 日韩有码中文字幕| 男女那种视频在线观看| 午夜日韩欧美国产| 一级黄片播放器| 免费在线观看影片大全网站| 美女 人体艺术 gogo| a在线观看视频网站| 18禁裸乳无遮挡免费网站照片| 色播亚洲综合网| 99riav亚洲国产免费| 国模一区二区三区四区视频| 在线观看午夜福利视频| tocl精华| 在线免费观看不下载黄p国产 | 一个人看视频在线观看www免费 | 夜夜夜夜夜久久久久| 中文在线观看免费www的网站| 国产精品一区二区三区四区免费观看 | av中文乱码字幕在线| 99在线人妻在线中文字幕| 毛片女人毛片| 窝窝影院91人妻| 国产一级毛片七仙女欲春2| 久久精品国产清高在天天线| 日本一二三区视频观看| 99热这里只有是精品50| 变态另类成人亚洲欧美熟女| 成人三级黄色视频| 白带黄色成豆腐渣| av视频在线观看入口| 久久久久久久午夜电影| 久久久久久久午夜电影| 国产精品自产拍在线观看55亚洲| 99精品欧美一区二区三区四区| 在线免费观看的www视频| 长腿黑丝高跟| 亚洲av美国av| 露出奶头的视频| av在线天堂中文字幕| 岛国在线免费视频观看| 人妻久久中文字幕网| 国产成人av教育| 亚洲欧美精品综合久久99| 欧美中文日本在线观看视频| www日本在线高清视频| 18禁黄网站禁片免费观看直播| 黄色视频,在线免费观看| 欧美色欧美亚洲另类二区| 亚洲中文日韩欧美视频| 亚洲美女黄片视频| 一个人免费在线观看电影| xxxwww97欧美| 天天一区二区日本电影三级| 日韩 欧美 亚洲 中文字幕| 免费看美女性在线毛片视频| 色av中文字幕| 久久国产精品影院| 91麻豆精品激情在线观看国产| 中亚洲国语对白在线视频| 亚洲第一欧美日韩一区二区三区| 精品福利观看| 久久中文看片网| 日韩高清综合在线| 国产精品一区二区免费欧美| 国内少妇人妻偷人精品xxx网站| 国产欧美日韩精品亚洲av| 久9热在线精品视频| 脱女人内裤的视频| 此物有八面人人有两片| 超碰av人人做人人爽久久 | 人妻丰满熟妇av一区二区三区| 亚洲 欧美 日韩 在线 免费| 国产国拍精品亚洲av在线观看 | 又黄又爽又免费观看的视频| 日本 av在线| 51午夜福利影视在线观看| 成年女人永久免费观看视频| bbb黄色大片| 亚洲精品粉嫩美女一区| 老司机福利观看| 无人区码免费观看不卡| 欧美成人一区二区免费高清观看| 俺也久久电影网| 国产精品美女特级片免费视频播放器| 亚洲av不卡在线观看| 亚洲av成人精品一区久久| 在线观看舔阴道视频| 精品不卡国产一区二区三区| 中文字幕av成人在线电影| 五月伊人婷婷丁香| 国产私拍福利视频在线观看| 欧美黑人欧美精品刺激| 欧美日韩中文字幕国产精品一区二区三区| 久久九九热精品免费| 国产成人a区在线观看| 不卡一级毛片| 嫩草影院精品99| 久久久久性生活片| 色老头精品视频在线观看| 男女做爰动态图高潮gif福利片| 欧美xxxx黑人xx丫x性爽| 亚洲天堂国产精品一区在线| 99久久久亚洲精品蜜臀av| 有码 亚洲区| 午夜激情欧美在线| 亚洲va日本ⅴa欧美va伊人久久| 五月伊人婷婷丁香| 日韩高清综合在线| 日本三级黄在线观看| 老司机午夜福利在线观看视频| 夜夜看夜夜爽夜夜摸| 国产午夜精品论理片| 亚洲精品一卡2卡三卡4卡5卡| 两个人的视频大全免费| 人人妻人人澡欧美一区二区| 18禁国产床啪视频网站| 日韩av在线大香蕉| 亚洲欧美日韩高清专用| 嫁个100分男人电影在线观看| 久久久久九九精品影院| 欧美色欧美亚洲另类二区| 午夜精品一区二区三区免费看| 女同久久另类99精品国产91| 国产成人福利小说| 狂野欧美激情性xxxx| 色老头精品视频在线观看| 国产91精品成人一区二区三区| 久久久色成人| 亚洲va日本ⅴa欧美va伊人久久| 久久99热这里只有精品18| 午夜福利视频1000在线观看| 在线国产一区二区在线| 久久这里只有精品中国| 日韩有码中文字幕| 国产精品乱码一区二三区的特点| 99精品欧美一区二区三区四区| 可以在线观看的亚洲视频| 成人永久免费在线观看视频| 国产精品,欧美在线| 久久久国产成人免费| 亚洲午夜理论影院| 欧美午夜高清在线| 热99re8久久精品国产| 两性午夜刺激爽爽歪歪视频在线观看| 日本精品一区二区三区蜜桃| 狂野欧美激情性xxxx| 女同久久另类99精品国产91| 国产精品爽爽va在线观看网站| 99久久综合精品五月天人人| 亚洲精品在线美女| 亚洲性夜色夜夜综合| 精品99又大又爽又粗少妇毛片 | 欧美大码av| 每晚都被弄得嗷嗷叫到高潮| 成人午夜高清在线视频| 日日摸夜夜添夜夜添小说| 亚洲 国产 在线| 99国产精品一区二区蜜桃av| 丁香六月欧美| 免费av毛片视频| 操出白浆在线播放| 一级黄色大片毛片| 亚洲人与动物交配视频| 亚洲中文日韩欧美视频| www.色视频.com| 黄色片一级片一级黄色片| 国产探花极品一区二区| 久久中文看片网| 亚洲最大成人手机在线| 国产精品一区二区三区四区免费观看 | 夜夜夜夜夜久久久久| 国产精品1区2区在线观看.| 国产av不卡久久| 成年女人毛片免费观看观看9| 熟女电影av网| 亚洲七黄色美女视频| 日本一本二区三区精品| 午夜免费成人在线视频| 欧美成狂野欧美在线观看| 国产熟女xx| 高清日韩中文字幕在线| 久久草成人影院| 午夜福利在线观看免费完整高清在 | 久久6这里有精品| 国产 一区 欧美 日韩| 波多野结衣高清无吗| 精品久久久久久久末码| 国产亚洲精品一区二区www| 国产精品久久久久久精品电影| 可以在线观看的亚洲视频| 久久久久国产精品人妻aⅴ院| 久久久久久久久久黄片| 欧美极品一区二区三区四区| av中文乱码字幕在线| 中国美女看黄片| 亚洲中文日韩欧美视频| 久久久久久久久大av| 国产麻豆成人av免费视频| 在线十欧美十亚洲十日本专区| 99精品欧美一区二区三区四区| 美女高潮的动态| 日韩中文字幕欧美一区二区| 国产精品免费一区二区三区在线| 69人妻影院| 少妇的逼好多水| 悠悠久久av| 五月伊人婷婷丁香| 欧美性感艳星| 国产中年淑女户外野战色| 精品久久久久久久久久久久久| 成人精品一区二区免费| 国产一区二区三区视频了| 午夜a级毛片| 我要搜黄色片| 狂野欧美白嫩少妇大欣赏| 国产色爽女视频免费观看| 成年版毛片免费区| 欧美在线黄色| 丰满乱子伦码专区| 美女 人体艺术 gogo| 精品一区二区三区av网在线观看| 成人特级黄色片久久久久久久| www.999成人在线观看| 国产成人欧美在线观看| 中文字幕av成人在线电影| 欧美成人a在线观看| 亚洲中文日韩欧美视频| 波多野结衣高清作品| 国产v大片淫在线免费观看| 人妻夜夜爽99麻豆av| 久久6这里有精品| 成人精品一区二区免费| 日本精品一区二区三区蜜桃| 99热这里只有精品一区| 亚洲国产精品sss在线观看| 亚洲欧美日韩高清专用| 精品福利观看| av视频在线观看入口| 国产精品野战在线观看| 97超视频在线观看视频| 国产精品亚洲av一区麻豆| 久久精品91蜜桃| 一个人免费在线观看电影| 级片在线观看| av福利片在线观看| 国产精品亚洲美女久久久| 麻豆一二三区av精品| 99久久久亚洲精品蜜臀av| 高清日韩中文字幕在线| 男女之事视频高清在线观看| x7x7x7水蜜桃| 久久国产精品人妻蜜桃| 国产极品精品免费视频能看的| 午夜免费观看网址| 亚洲五月婷婷丁香| 尤物成人国产欧美一区二区三区| 日韩精品中文字幕看吧| 久久这里只有精品中国| 免费搜索国产男女视频| 日本三级黄在线观看| av福利片在线观看| 老汉色av国产亚洲站长工具| 在线观看日韩欧美| 国产亚洲精品综合一区在线观看| 变态另类丝袜制服| 精品久久久久久久久久久久久| 搡老岳熟女国产| 免费在线观看亚洲国产| 好男人电影高清在线观看| 亚洲最大成人手机在线| 动漫黄色视频在线观看| 午夜老司机福利剧场| 亚洲va日本ⅴa欧美va伊人久久| 亚洲av日韩精品久久久久久密| 两个人看的免费小视频| 18禁黄网站禁片免费观看直播| 成人无遮挡网站| 欧美3d第一页| 在线免费观看不下载黄p国产 | 黄片小视频在线播放| 禁无遮挡网站| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | xxx96com| 日韩欧美国产一区二区入口| 久久久国产成人免费| 久久国产精品影院| 国产精品 国内视频| 在线观看舔阴道视频| 国产成人福利小说| 99精品在免费线老司机午夜| 免费电影在线观看免费观看| 校园春色视频在线观看| 色噜噜av男人的天堂激情| 夜夜夜夜夜久久久久| 国产乱人视频| 日韩亚洲欧美综合| 欧美日韩黄片免| 午夜福利在线观看吧| 国产成+人综合+亚洲专区| 国产一区二区激情短视频| www.熟女人妻精品国产| 一级a爱片免费观看的视频| 国产精品 国内视频| 欧美日韩国产亚洲二区| 舔av片在线| a级一级毛片免费在线观看| 美女高潮喷水抽搐中文字幕| 精品99又大又爽又粗少妇毛片 | 看黄色毛片网站| 男女床上黄色一级片免费看| 黑人欧美特级aaaaaa片| 美女黄网站色视频| 国产精品 欧美亚洲| 嫩草影视91久久| 美女cb高潮喷水在线观看| 婷婷亚洲欧美| 亚洲aⅴ乱码一区二区在线播放| 9191精品国产免费久久| 久久久久久国产a免费观看| 国产探花在线观看一区二区| 19禁男女啪啪无遮挡网站| 日韩欧美国产在线观看| 91麻豆精品激情在线观看国产| 99热这里只有精品一区| 久久这里只有精品中国| 中文字幕免费在线视频6| 亚洲成人精品中文字幕电影| 免费看日本二区| 亚洲精品,欧美精品| 午夜激情欧美在线| 国产黄色免费在线视频| 水蜜桃什么品种好| 男女啪啪激烈高潮av片| 麻豆乱淫一区二区| 自拍偷自拍亚洲精品老妇| 在线免费观看不下载黄p国产| 亚洲精品aⅴ在线观看| 国内精品宾馆在线| 边亲边吃奶的免费视频| 水蜜桃什么品种好| 亚洲精品亚洲一区二区| 国产精品一二三区在线看| 男女边摸边吃奶| 久99久视频精品免费| 国产一级毛片七仙女欲春2| 国模一区二区三区四区视频| 全区人妻精品视频| 久久久色成人| 午夜福利网站1000一区二区三区| 亚洲欧美中文字幕日韩二区| 91久久精品电影网| 亚洲人与动物交配视频| 人人妻人人澡欧美一区二区| 免费看日本二区| 久久99蜜桃精品久久| 精品一区二区三区视频在线| 国产伦一二天堂av在线观看| 只有这里有精品99| 白带黄色成豆腐渣| 亚洲国产欧美在线一区| 午夜爱爱视频在线播放| 久久久久久久久中文| 最新中文字幕久久久久| 春色校园在线视频观看| 美女被艹到高潮喷水动态| 免费观看a级毛片全部| 亚洲高清免费不卡视频| 国产探花在线观看一区二区| 久久热精品热| 一级毛片久久久久久久久女| 精品人妻一区二区三区麻豆| 欧美xxⅹ黑人| 床上黄色一级片| 午夜激情欧美在线| 精品酒店卫生间| 日韩大片免费观看网站| 狂野欧美白嫩少妇大欣赏| 欧美日韩一区二区视频在线观看视频在线 | 婷婷六月久久综合丁香| 老师上课跳d突然被开到最大视频| 免费电影在线观看免费观看| 联通29元200g的流量卡| or卡值多少钱| 天天一区二区日本电影三级| 91久久精品国产一区二区成人| 国产精品一区二区在线观看99 | 国内精品一区二区在线观看| 国产成人a∨麻豆精品| 看十八女毛片水多多多| 午夜免费激情av| 三级国产精品欧美在线观看| 最近2019中文字幕mv第一页| 亚洲成人精品中文字幕电影| 精品久久久久久成人av| 亚洲一级一片aⅴ在线观看| 国产成人精品一,二区| 天堂√8在线中文| 啦啦啦韩国在线观看视频| 国产精品日韩av在线免费观看| 国产精品人妻久久久久久| 美女xxoo啪啪120秒动态图| 特级一级黄色大片| 欧美成人a在线观看| 熟女电影av网| 精品久久久久久久末码| 搞女人的毛片| 亚洲国产欧美人成| 一本久久精品| 一本一本综合久久| 国产日韩欧美在线精品| 少妇人妻一区二区三区视频| 日韩强制内射视频| 69av精品久久久久久| 十八禁国产超污无遮挡网站| 国产一区二区三区av在线| 国产精品久久视频播放| 小蜜桃在线观看免费完整版高清| 亚洲av男天堂| 久久草成人影院| 亚洲精品视频女| 男人和女人高潮做爰伦理| 波野结衣二区三区在线| 亚洲av一区综合| 国产精品麻豆人妻色哟哟久久 | 一区二区三区免费毛片| 伦精品一区二区三区| 麻豆国产97在线/欧美| 男女那种视频在线观看| 六月丁香七月| 免费观看精品视频网站| 国产亚洲午夜精品一区二区久久 | 在线天堂最新版资源| 在线免费十八禁| 亚洲av国产av综合av卡| 中文字幕免费在线视频6| 色吧在线观看| 免费看不卡的av| 亚洲欧美日韩卡通动漫| 在线天堂最新版资源| 熟女人妻精品中文字幕| 少妇人妻一区二区三区视频| 中文在线观看免费www的网站| 日本猛色少妇xxxxx猛交久久| 亚洲性久久影院| 性插视频无遮挡在线免费观看| 亚洲第一区二区三区不卡| 三级毛片av免费| 3wmmmm亚洲av在线观看| 免费少妇av软件| 中国国产av一级| h日本视频在线播放| 毛片女人毛片| 国产精品福利在线免费观看| av黄色大香蕉| 男女国产视频网站| 国产黄片美女视频| 老司机影院成人| 国产精品国产三级专区第一集| 中文字幕免费在线视频6| 亚洲自偷自拍三级| 国产精品av视频在线免费观看| av在线老鸭窝| 亚洲av电影在线观看一区二区三区 | 人人妻人人澡人人爽人人夜夜 | 国产老妇女一区| 日韩 亚洲 欧美在线| 哪个播放器可以免费观看大片| 别揉我奶头 嗯啊视频| 97超视频在线观看视频| 日韩成人伦理影院| 大片免费播放器 马上看| 永久免费av网站大全| 国产单亲对白刺激| 99久久中文字幕三级久久日本| 午夜免费观看性视频| 69人妻影院| 国产午夜福利久久久久久| 亚洲精品第二区| 久久精品夜夜夜夜夜久久蜜豆| 欧美97在线视频| 欧美性感艳星| 国产有黄有色有爽视频| 国产精品一二三区在线看| 久久久成人免费电影| 99久久精品一区二区三区| 久久97久久精品| 国产一级毛片七仙女欲春2| 色视频www国产| 亚洲av男天堂| 中国美白少妇内射xxxbb| 午夜福利在线观看吧| 中文字幕av成人在线电影| 中文字幕免费在线视频6| 一级片'在线观看视频| 欧美+日韩+精品| 午夜福利视频1000在线观看| 亚洲乱码一区二区免费版| 午夜久久久久精精品| 成人特级av手机在线观看| 精品酒店卫生间| 国产精品久久久久久精品电影小说 | 免费av观看视频| 少妇猛男粗大的猛烈进出视频 | 色5月婷婷丁香| 亚洲图色成人| 精品国产一区二区三区久久久樱花 | 国产亚洲91精品色在线| 又爽又黄a免费视频| 日韩不卡一区二区三区视频在线| 国产一区亚洲一区在线观看| 国产乱人偷精品视频| 2022亚洲国产成人精品| 一级av片app| 亚洲精品久久久久久婷婷小说| 久久久久久久国产电影| 亚洲国产精品sss在线观看| 人妻少妇偷人精品九色| 少妇人妻一区二区三区视频| 日本黄色片子视频| 久久精品久久久久久噜噜老黄| 韩国高清视频一区二区三区| 免费观看a级毛片全部| 欧美3d第一页| 免费电影在线观看免费观看| 极品少妇高潮喷水抽搐| 国产视频首页在线观看| 中文字幕av在线有码专区| 午夜福利视频精品| 九草在线视频观看| 亚洲va在线va天堂va国产| 亚洲av二区三区四区| 嫩草影院新地址| 尾随美女入室| 激情 狠狠 欧美| 日韩视频在线欧美| 亚洲精品久久午夜乱码| 国产伦一二天堂av在线观看| 亚洲国产最新在线播放| 人体艺术视频欧美日本| 51国产日韩欧美| 男女啪啪激烈高潮av片| 亚洲av电影不卡..在线观看| 精品人妻视频免费看| 国产精品麻豆人妻色哟哟久久 | 直男gayav资源| 国产精品久久久久久久电影| av卡一久久| 免费av不卡在线播放| 国产麻豆成人av免费视频| 国产精品综合久久久久久久免费| 欧美极品一区二区三区四区| av国产免费在线观看| 亚洲三级黄色毛片| 亚洲av福利一区| 亚洲最大成人中文| 久久精品久久精品一区二区三区| 成人毛片a级毛片在线播放| 国产人妻一区二区三区在| 亚洲自拍偷在线| 国产一级毛片在线| 天堂√8在线中文| 成人综合一区亚洲| 国精品久久久久久国模美| 久久鲁丝午夜福利片| 欧美性猛交╳xxx乱大交人| 久久久久久久久久人人人人人人| 偷拍熟女少妇极品色| 在线天堂最新版资源| 最后的刺客免费高清国语| 国产三级在线视频| 国产亚洲一区二区精品| 我的女老师完整版在线观看| 极品少妇高潮喷水抽搐| 国产精品女同一区二区软件| 人妻一区二区av| 亚洲四区av| 人体艺术视频欧美日本| 国产人妻一区二区三区在| 国产成人91sexporn| 国产乱人偷精品视频| 午夜亚洲福利在线播放| 十八禁网站网址无遮挡 | 欧美日韩亚洲高清精品| 久久人人爽人人爽人人片va| 老女人水多毛片| 日韩成人av中文字幕在线观看| 免费看不卡的av| 舔av片在线| 久久久久久久久久人人人人人人| 好男人在线观看高清免费视频| 26uuu在线亚洲综合色| 久久精品国产亚洲av天美| 我要看日韩黄色一级片| av在线亚洲专区| 在线 av 中文字幕|